Abstract
6069 Background: HIV+ patients (pts) are typically excluded from enrollment on randomized clinical trials for head and neck cancer. Data regarding clinical characteristics and outcomes for HIV+ pts...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have